Prof. Dr. med. Dirk Wedekind

Name Card

Main Affiliation
 
Staff Status
unigoe
 

1-18 of 18
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2022 | Journal Article | Research Paper | 
    ​ ​Internet psychotherapeutic interventions for anxiety disorders – a critical evaluation​
    Bandelow, B.   & Wedekind, D. ​ (2022) 
    BMC Psychiatry, 22(1) art. 441​.​ DOI: https://doi.org/10.1186/s12888-022-04002-1 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder​
    Hart, X. M.; Heesen, S.; Schmitz, C. N.; Dörfler, S.; Wedekind, D. ; Gründer, G. & Hiemke, C. et al.​ (2022) 
    European Archives of Psychiatry and Clinical Neuroscience,.​ DOI: https://doi.org/10.1007/s00406-022-01491-9 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Validation of the extended version of the Dissociative Experiences Scale (DES) in patients diagnosed with substance use disorders​
    Gidzgier, P.; Driessen, M.; Gawęda, Ł.; Havemann-Reinecke, U. ; Wedekind, D. ; Lüdecke, C. & Ohlmeier, M. et al.​ (2021) 
    Journal of Substance Use, pp. 1​-5​.​ DOI: https://doi.org/10.1080/14659891.2021.1941357 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer’s disease​
    Santos, J. R. F.; Bauer, C.; Schuchhardt, J.; Wedekind, D. ; Waniek, K.; Lachmann, I. & Wiltfang, J.  et al.​ (2019) 
    Journal of Neural Transmission, 126(3) pp. 339​-348​.​ DOI: https://doi.org/10.1007/s00702-019-01982-5 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Network analyses to rank pharmacological treatments for generalised anxiety disorder​
    Bandelow, B.   & Wedekind, D. ​ (2019) 
    The Lancet, 393(10173) pp. 721​-722​.​ DOI: https://doi.org/10.1016/S0140-6736(18)32180-9 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Angebot und Inanspruchnahme von Sporttherapie in psychiatrischen Kliniken in Deutschland​
    Brehm, K.; Dallmann, P.; Freyer, T.; Winter, K.; Malchow, B.; Wedekind, D.   & Diller, I.-M. et al.​ (2019) 
    Der Nervenarzt, 91(7) pp. 642​-650​.​ DOI: https://doi.org/10.1007/s00115-019-0782-7 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice​
    Timäus, C.; Meiser, M.; Bandelow, B. ; Engel, K. R. ; Paschke, A. M.; Wiltfang, J.   & Wedekind, D. ​ (2019) 
    BMC Psychiatry, 19(1).​ DOI: https://doi.org/10.1186/s12888-019-2377-z 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​The Role of Proopiomelanocortin and α-Melanocyte-Stimulating Hormone in the Metabolic Syndrome in Psychiatric Disorders: A Narrative Mini-Review​
    Raue, S.; Wedekind, D. ; Wiltfang, J.   & Schmidt, U.​ (2019) 
    Frontiers in Psychiatry, 10.​ DOI: https://doi.org/10.3389/fpsyt.2019.00834 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies​
    Bandelow, B. ; Sagebiel, A.; Belz, M. ; Görlich, Y.; Michaelis, S.   & Wedekind, D. ​ (2018) 
    The British Journal of Psychiatry, 212(6) pp. 333​-338​.​ DOI: https://doi.org/10.1192/bjp.2018.49 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Authors' reply​
    Bandelow, B. ; Sagebiel, A.; Belz, M. ; Görlich, Y.; Michaelis, S.   & Wedekind, D. ​ (2018) 
    British Journal of Psychiatry, 214(1) pp. 53​-54​.​ DOI: https://doi.org/10.1192/bjp.2018.226 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Differential relationships of PTSD and childhood trauma with the course of substance use disorders​
    Mergler, M.; Driessen, M.; Havemann-Reinecke, U. ; Wedekind, D. ; Lüdecke, C.; Ohlmeier, M. & Chodzinski, C. et al.​ (2018) 
    Journal of Substance Abuse Treatment, 93 pp. 57​-63​.​ DOI: https://doi.org/10.1016/j.jsat.2018.07.010 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety—an MRI study​
    Uhlmann, A.; Bandelow, B. ; Stein, D. J.; Bloch, S.; Engel, K. R. ; Havemann-Reinecke, U.   & Wedekind, D. ​ (2018) 
    European Archives of Psychiatry and Clinical Neuroscience, 269(3) pp. 285​-294​.​ DOI: https://doi.org/10.1007/s00406-018-0870-x 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Reproducibility of Alzheimer’s Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions​
    Vogelgsang, J.; Wedekind, D. ; Bouter, C. ; Klafki, H.-W.   & Wiltfang, J. ​ (2018) 
    Journal of Alzheimer's Disease, 62(1) pp. 203​-212​.​ DOI: https://doi.org/10.3233/JAD-170793 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Influence of depressed patients' expectations prior to electroconvulsive therapy on its effectiveness and tolerability (Exp-ECT): a prospective study​
    Krech, L. ; Belz, M. ; Besse, M. ; Methfessel, I. ; Wedekind, D.   & Zilles, D. ​ (2018) 
    European Archives of Psychiatry and Clinical Neuroscience, 268(8) pp. 809​-817​.​ DOI: https://doi.org/10.1007/s00406-017-0840-8 
    ​Details  DOI  PMID  PMC 
  • 2017 | Journal Article
    ​ ​Relationships between a Dissociative Subtype of PTSD and Clinical Characteristics in Patients with Substance Use Disorders​
    Mergler, M.; Driessen, M.; Lüdecke, C.; Ohlmeier, M.; Chodzinski, C.; Weirich, S. & Schläfke, D. et al.​ (2017) 
    Journal of Psychoactive Drugs, 49(3) pp. 225​-232​.​ DOI: https://doi.org/10.1080/02791072.2017.1296209 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Neuropsychiatrische Erkrankungen und Demenzen: ein interdisziplinärer Ansatz​
    Zerr, I. ; Bandelow, B. ; Wedekind, D. ; Schneider, A. ; Radenbach, K. ; Wiltfang, J.   & Bähr, M. ​ (2016) 
    Aktuelle Neurologie, 43(06) pp. 369​-371​.​ DOI: https://doi.org/10.1055/s-0042-106719 
    ​Details  DOI 
  • 2015 | Journal Article
    ​ ​Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls​
    Engel, K. R. ; Obst, K. ; Bandelow, B. ; Dechent, P. ; Gruber, O. ; Zerr, I.   & Ulrich, K.  et al.​ (2015) 
    European Archives of Psychiatry and Clinical Neuroscience, 266(6) pp. 557​-566​.​ DOI: https://doi.org/10.1007/s00406-015-0653-6 
    ​Details  DOI 
  • 2011 | Conference Abstract
    ​ ​BORDERLINE PERSONALITY DISORDER - A DYSREGULATION OF THE ENDOGENOUS OPIOID SYSTEM?​
    Bandelow, B. ; Schmahl, C.; Falkai, P. G.   & Wedekind, D. ​ (2011)
    European Psychiatry, 26 
    Paris​: Elsevier France-editions Scientifiques Medicales Elsevier.
    ​Details  WoS 

Publication List

All Articles (Book & Journal) Conference objects Articles & Preprints Papers (Journal & Conference)

Type

Subtype

Date issued

Author

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp01624
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.